Joseph Raybon - Concepedia

Author

Joseph Raybon

Bristol-Myers Squibb (United States)

Also Known As

J. Raybon, Joseph J. Raybon, Joseph Raybon, Raybon, Joseph

Publications

424

Citations

H-Index

Concepts

All Affiliations

Bristol-Myers Squibb (United States)Pfizer (United States)University at Buffalo, State University of New York GlaxoSmithKline (United States)Teva Pharmaceuticals (United States)

About

Joseph Raybon is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	192
2	Biochemistry	3	3	112
3	Natural Sciences	2	2	99
4	Social Sciences	1	1	13
5	Immunology	1	1	31

Joseph Raybon

Publications

403

Citations

H-Index

Page 1

	Year	Citations
Discovery of Isonicotinamides as Highly Selective, Brain Penetrable, and Orally Active Glycogen Synthase Kinase-3 Inhibitors Guanglin Luo, Ling Chen, Catherine R. Burton, Journal of Medicinal Chemistry Chemoprevention StrategyKinase-selective Gsk-3 InhibitorsPharmacotherapyMedicinal ChemistryReceptor Tyrosine Kinase	2016	68
Pharmacodynamics of Selective Inhibition of γ-Secretase by Avagacestat Charles F. Albright, Randy Dockens, Jere E. Meredith, Journal of Pharmacology and Experimental Therapeutics	2012	63
Preclinical Pharmacokinetic/Pharmacodynamic Modeling and Simulation in the Pharmaceutical Industry: An IQ Consortium Survey Examining the Current Landscape Edgar Schuck, Tonika Bohnert, Arijit Chakravarty, The AAPS Journal Translational MedicinePharmacokinetic ModelingPharmacologyIq Consortium SurveyCurrent Landscape	2015	51
The γ-Secretase Modulator, BMS-932481, Modulates Aβ Peptides in the Plasma and Cerebrospinal Fluid of Healthy Volunteers Holly Soares, Maciej Gąsior, Jeremy H. Toyn, Journal of Pharmacology and Experimental Therapeutics	2016	45
Neuroinflammatory Role of Prostaglandins during Experimental Meningitis: Evidence Suggestive of an in Vivo Relationship between Nitric Oxide and Prostaglandins Kathleen M.K. Boje, David Jaworowicz, Joseph Raybon Journal of Pharmacology and Experimental Therapeutics	2003	40
Discovery of a Hepatitis C Virus NS5B Replicase Palm Site Allosteric Inhibitor (BMS-929075) Advanced to Phase 1 Clinical Studies Kap‐Sun Yeung, Brett R. Beno, Kyle Parcella, Journal of Medicinal Chemistry Hepatitis C VirusImmunologyMolecular BiologyNs5b ReplicaseAntiviral Drug	2017	31
Liquid chromatographic–mass spectrometric determination of endogenous γ-hydroxybutyrate concentrations in rat brain regions and plasma Ho‐Leung Fung, E J de Haas, Joseph Raybon, Journal of Chromatography B Endogenous γ-Hydroxybutyrate ConcentrationsRat Brain RegionsMedicineMass SpectrometryBiological Mass Spectrometry	2004	29
Pharmacokinetics and Pharmacodynamics of γ-Hydroxybutyric Acid during Tolerance in Rats: Effects on Extracellular Dopamine Joseph Raybon, Kathleen M.K. Boje Journal of Pharmacology and Experimental Therapeutics	2006	27
Robust Translation of γ-Secretase Modulator Pharmacology across Preclinical Species and Human Subjects Jeremy H. Toyn, Kenneth M. Boy, Joseph Raybon, Journal of Pharmacology and Experimental Therapeutics	2016	25
Identification and Preclinical Pharmacology of the<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mrow><mml:mi mathvariant="bold-italic">γ</mml:mi></mml:mrow></mml:math>-Secretase Modulator BMS-869780 Jeremy H. Toyn, Lorin A. Thompson, Kimberley A. Lentz, International Journal of Alzheimer s Disease Pharmaceutical ScienceNeurochemical BiomarkersPeptide ScienceSystem PharmacologyExperimental Pharmacology	2014	13

Page 1